Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by nemo3on Mar 09, 2019 10:16am

168 Views

Post# 29465040

2Q 2019 for enrollment

On Theralase website, it still states that the actual enrollment will commence in the 2Q 2019. So we still might have a bit of a wait ahead of us for the clincial trial to actually start....but getting closer. For so many patients, I hope that this does turn into a viable treatment for previously deadly cancers.

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading